SLBT

SL Science Holding Ltd

There isn't enough reported data to score SLBT yet.

SLBT Fundamentals

MetricStatus
Unavailable
Unavailable
Unavailable
Unavailable

There isn't enough reported data to rate SLBT's fundamentals.

SLBT PE Valuation

SLBT has no meaningful PE right now: it lost money over the past year.

SLBT Forward outlook

There aren't enough analyst estimates for SLBT to show an outlook.

SLBT Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $0.76 on Nov 12.

There is not enough scenario data to assess SLBT's risk to reward.

SLBT Earnings Per Share

SLBT Quarterly Revenue

Q4 2024: --Q1 2025: $565Q2 2025: $565Q4 2025: --
Q4 2024: --Q1 2025: $565Q2 2025: $565Q4 2025: --

SLBT Free Cash Flow

Q4 2024: --Q1 2025: −$225Q2 2025: −$225Q4 2025: --
Q4 2024: --Q1 2025: −$225Q2 2025: −$225Q4 2025: --

SLBT Total Shares

Q1 2025: 3,675Q2 2025: 3,675
Q1 2025: 3,675Q2 2025: 3,675
PeriodChange %Net change
Quarterly0%--

SLBT Net Leverage

SLBT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

SLBT Weekly Momentum

MetricValueStatus
RSI44.0Neutral
Stochastic6.8Oversold

SLBT's weekly RSI is 44 (neutral) and its Stochastic is 7 (oversold).

SLBT PE vs Healthcare Sector

SLBT has no meaningful PE right now: it lost money over the past year.

SLBT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$1.2841% below
20 week MA$2.4269% below

SLBT is in a downtrend: it's below all two of its weekly moving averages, and 69% below its 20-week average.

SLBT Yearly ROI

YearStart priceEnd priceROI
2026 YTD$8.75$0.76-91%

It's down 91% so far in 2026.

Give your agent the market.

Get API key